Therapeutics: α-hemolysin (aHL) Patent application filed; unavailable for licensing

In vitro and mouse studies suggest a mAb against multiple Staphylococcus aureus hemolysin and leukocidin toxins could help treat bacterial infection. A yeast display screen of human antibodies identif...